MODERNA INC (MRNA) Forecast, Price Target & Analyst Ratings
NASDAQ:MRNA • US60770K1079
55.97 USD
+0.99 (+1.8%)
At close: Mar 11, 2026
55.45 USD
-0.52 (-0.93%)
Pre-Market: 3/12/2026, 6:29:01 AM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MODERNA INC (MRNA).
Forecast Snapshot
Consensus Price Target
$42.49
-24.09% Downside
Next Earnings Forecast
Release DateApr 29, 2026
PeriodQ1 / 2026
EPS Estimate-$2.12
Revenue Estimate232.19M
ChartMill Buy Consensus
56.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$42.49
Upside
-24.09%
From current price of $55.97 to mean target of $42.49, Based on 30 analyst forecasts
Low
$12.12
Median
$36.72
High
$141.75
Price Target Revisions
1 Month
7.07%
3 Months
11.61%
Price Target Summary
30 Wall Street analysts provided a forecast for the next 12 months for MRNA. The average price target is 42.49 USD. This implies a price decrease of -24.09% is expected in the next year compared to the current price of 55.97.
The average price target has been revised upward by 11.61% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
56.00%
MRNA was analyzed by 30 analysts. The buy percentage consensus is at 56. So analysts seem to be rather neutral about MRNA.
In the previous month the buy percentage consensus was at a similar level.
MRNA was analyzed by 30 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-23 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2026-02-17 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2026-02-17 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-02-17 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2025-12-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-12 | Jefferies | Initiate | Hold |
| 2025-11-21 | Leerink Partners | Maintains | Underperform -> Underperform |
| 2025-11-21 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-11-21 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-11-10 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-11-07 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-23 | UBS | Maintains | Buy -> Buy |
| 2025-10-23 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-10-23 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-10-20 | Needham | Reiterate | Hold -> Hold |
| 2025-10-10 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-22 | Leerink Partners | Maintains | Underperform -> Underperform |
| 2025-08-04 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-22 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-05-22 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-05-02 | UBS | Maintains | Buy -> Buy |
| 2025-05-02 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-05-02 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-02 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-04-09 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 29, 2026
PeriodQ1 / 2026
EPS Estimate-$2.12
Revenue Estimate232.19M
Revenue Q2Q114.99%
EPS Q2Q15.79%
Number of Analysts17
Next Earnings Revisions
Revenue (1 Month)
-9.95%
Revenue (3 Months)
6.41%
EPS (1 Month)
9.04%
EPS (3 Months)
11.41%
Next Earnings Summary
MRNA is expected to report earnings on 4/29/2026. The consensus EPS estimate for the next earnings is -2.12 USD and the consensus revenue estimate is 232.19M USD.
The next earnings revenue estimate has been revised upward by 6.41% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.848B -64.45% | 3.236B -52.75% | 1.944B -39.93% | 2.105B 8.28% | 2.453B 16.53% | 2.956B 20.51% | 5.322B 80.04% | 6.957B 30.72% | 5.795B -16.70% | 6.657B 14.87% | 7.673B 15.26% | |
| EBITDA YoY % growth | -1.418B -114.52% | -3.261B -129.97% | -2.568B 21.25% | -2.531B 1.44% | -1.735B 31.46% | -923.018M 46.80% | 328.13M 135.55% | 1.958B 496.71% | 2.592B 32.38% | 3.204B 23.61% | 3.833B 19.63% | |
| EBIT YoY % growth | -2.039B -121.65% | -3.45B -69.20% | -2.783B 19.33% | -2.861B -2.81% | -2.102B 26.54% | -1.314B 37.50% | 205.57M 115.65% | 1.494B 626.76% | 1.508B 0.94% | 2.337B 54.97% | 2.829B 21.05% | |
| Operating Margin | -29.78% | -106.61% | -143.16% | -135.93% | -85.68% | -44.44% | 3.86% | 21.47% | 26.02% | 35.11% | 36.87% | |
| EPS YoY % growth | -12.41 -162.17% | -9.28 25.22% | -7.27 21.66% | -6.81 6.26% | -4.94 27.49% | -3.29 33.32% | 0.58 117.67% | 3.98 582.95% | 3.19 -19.84% | 4.53 42.08% | 5.93 30.86% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -2.12 15.79% | -2.14 -0.48% | -1.13 -121.43% | -1.28 39.44% |
| Revenue Q2Q % growth | 232.19M 114.99% | 127.67M -10.09% | 911.82M -10.25% | 706.85M 4.26% |
| EBITDA Q2Q % growth | -1.064B -9.76% | -1.089B -40.92% | -454.794M -910.65% | N/A |
| EBIT Q2Q % growth | -879.986M 12.70% | -894.68M -2.96% | -481.092M -149.27% | -629.215M 11.75% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
15.65%
EPS Next 5 Year
20.56%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
15.33%
Revenue Next 5 Year
29.27%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
20.09%
EBIT Next 5 Year
20.77%
MODERNA INC / MRNA Forecast FAQ
Can you provide the average price target for MODERNA INC stock?
30 analysts have analysed MRNA and the average price target is 42.49 USD. This implies a price decrease of -24.09% is expected in the next year compared to the current price of 55.97.
What is the next earnings date for MRNA stock?
MODERNA INC (MRNA) will report earnings on 2026-04-29, before the market open.
What are the consensus estimates for MODERNA INC (MRNA) next earnings?
The consensus EPS estimate for the next earnings of MODERNA INC (MRNA) is -2.12 USD and the consensus revenue estimate is 232.19M USD.
How many analysts cover MODERNA INC (MRNA) stock?
The number of analysts covering MODERNA INC (MRNA) is 30.